Mesenchymal-like adherent stromal cell therapy(Celularity)

N/A

Report date: 2025/01/21 17:01:35

Base Information

Drug NameMesenchymal-like adherent stromal cell therapy(Celularity)
Drug Alias NameMLASC(Celularity)
ClassificationCell and gene therapy > Cell therapy
Mechanisms of ActionCell replacements
TargetsUpdating
Therapy Area/IndicationsNerve DegenerationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCelularity Inc
China Registration ClassN/A

Develop Information

Active CompaniesCelularity Inc
Inactive CompaniesN/A
Active IndicationsNerve DegenerationAutoimmune Diseases
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A